Haya Ascher‐Svanum

Author

Haya Ascher‐Svanum

Eli Lilly (United States)

Also Known As

H ASCHERSVANUM, H Ascher-Svanum, H. Ascher-Svanum, Haya Ascher-Svanum, Haya Ascher‐Svanum

232

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Zucker Hillside Hospital Eli Lilly (United Kingdom)Indiana University – Purdue University Indianapolis King's College London

About

Haya Ascher‐Svanum is an author at Eli Lilly (United States) specializing in psychiatry, medicine, and schizophrenia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	30	1.5K
2	Nursing	2	2	40
3	Education	1	1	26
4	Health Sciences	1	1	13
5	Public Health	1	1	71

Haya Ascher‐Svanum

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu, The Journal of Clinical Psychiatry	2006	476
The burden of depressive symptoms in the long-term treatment of patients with schizophrenia R. Conley, Haya Ascher‐Svanum, Baojin Zhu, Schizophrenia Research PsychopathologyPsychiatryPsychotic DisorderMedicineLong-term Treatment	2006	281
The cost of relapse and the predictors of relapse in the treatment of schizophrenia Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries, BMC Psychiatry	2010	274
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics Douglas E. Faries, Haya Ascher‐Svanum, Baojin Zhu, BMC Psychiatry	2005	183
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia Bruce J. Kinon, Lei Chen, Haya Ascher‐Svanum, Neuropsychopharmacology Subsequent ResponseAntipsychotic Drug TherapyEarly ResponsePsychiatryPsychotic Disorder	2009	175
Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆ Bruce J. Kinon, Lichang Chen, Haya Ascher‐Svanum, Schizophrenia Research Early ResponsePsychiatryPsychotic DisorderAtypical AntipsychoticsPsychotropic Medication	2008	165
Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response Jean-Pierre Lindenmayer, Hong Liu‐Seifert, Pandurang M. Kulkarni, The Journal of Clinical Psychiatry	2009	161
A Prospective Study of Risk Factors for Nonadherence With Antipsychotic Medication in the Treatment of Schizophrenia Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries, The Journal of Clinical Psychiatry	2006	145
Characteristics and Use Patterns of Patients Taking First-Generation Depot Antipsychotics or Oral Antipsychotics for Schizophrenia Lizheng Shi, Haya Ascher‐Svanum, Baojin Zhu, Psychiatric Services	2007	112
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries, BMC Psychiatry	2006	110

Page 1